Apte-Medica 2sp. z o.o.

Dispensing chemist in specialised stores

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2017-03-20
Share capital
5,000.00 PLN
Registered address
ul. Żwirki I Wigury 16A/Biuro 315, 02-092 Warszawa, Poland
Electronic delivery address
AE:PL-92838-93278-JHJEA-29

Financials

Revenue history (in k)

Financial insight

  • The statement flags a going concern risk. Na dzień 31 grudnia 2025 r. skumulowane straty wyniosły 1567534,31 zł i przewyższyły sumę kapitału zapasowego i kapitałów rezerwowych oraz połowę kapitału zakładowego o kwotę 1565034,31 zł. Stosownie do wymogów art. 233 ustawy z dnia 07.12.2023 r. KSH (Dz.U. z 2024 r. poz. 18. z póżniejszymi zmianami) Nadzwyczajne Zgromadzenie Wspólników w dniu 06.03.2026 podjeło uchwałę o kontynuowaniu działalności firmy.

From the notes

Current income tax (CIT due)$0
Profit allocationLoss to be covered
Contingent liabilities$29,296,062

Filing timeliness

3 of 6 financial statements were filed late (the longest delay 68 days for 2021).

  • 202515/07/2026
  • 202414/07/2025
  • 202318/07/2024
  • 202215/08/2023
  • 202121/09/2022
  • 202008/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Statistics

How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.

Industry · Dispensing chemist in specialised stores975 / 1,512
Top 64%
Division · Retail trade4,397 / 9,929
Top 44%
Sector · Wholesale and retail trade; repair of motor vehicles including motorcycles13,103 / 29,939
Top 44%
City · Warszawa13,977 / 57,023
Top 25%
Voivodeship · Mazowieckie19,600 / 77,210
Top 25%
Country · Poland77,551 / 298,279
Top 26%

Results vs industry

Revenue
This companyUSD 1.35mMedianUSD 1.92mAverageUSD 5.20m
Net profit
This companyUSD -36.94kMedianUSD 20.70kAverageUSD 86.94k
Operating costs
This companyUSD 1.35mMedianUSD 1.88mAverageUSD 5.04m
Assets
This companyUSD 212.47kMedianUSD 543.65kAverageUSD 1.76m

Industry

Authorized Representatives

Grzegorz Andrzej Bajtałaage 51 – President of the Management Board

Manner of representation

If the management board is a multi-member management board, joint action of two members of the management board, or one member of the management board together with a commercial proxy, is required to make declarations on behalf of the company. If the management board is a one-person management board, the President of the Management Board represents the company independently.

Ownership

OwnerSharesShare valueStake
Megafarm sp. z o.o.
100$1,350.62100%

Beneficial owners

Person

Bank accounts

Registered as a VAT taxpayer on 2017-03-22.

Debt

No entries in the National Debtors Register (KRZ).

Real estate

TypeAmount
Buildings and premises
PLN 7,066

Secured liabilities

Type
Registered pledge

Public aid

4 public aid cases recorded, with a total value of $6,855.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,733
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$2,123

Regulatory authorisations

AuthorityTypeStatus
BDO register entry Active

Competitors

Name
Cosmedicasp. z o.o.
DR ZdrowieS.A.
MagmaxS.A.
Novopharm - Millersp. j.
MaglowS.A.
Farmacja Im. O. Klimuszkisp. z o.o.
Nukloversp. z o.o.
Massmedsp. z o.o.
DR Farm K. Wenda Zakłady Przemysłowo-Handlowe w Warszawie z Siedzibą w WarszawieS.A.
Femaherbsp. z o.o.

Change history

DateEvent
2026-07-23PKD change
2023-10-10Address change
2023-10-10PKD change
2018-08-06Address change
2018-08-06PKD change

FAQ

Last updated: 2026-10-07